EUR 155.86 For Business Accounts Only

Alere Inc. - Strategy, SWOT and Corporate Finance Report

Summary
Alere Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Key Findings
- Detailed information on Alere Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Alere Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Alere Inc. including a breakdown and examination of key business segments
- Intelligence on Alere Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Alere Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends




Reasons To Buys
- Gain understanding of Alere Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Alere Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Alere Inc.'s business structure, strategy and prospects.

Key Highlights
Alere Inc. (Alere or ‘the company) is a leading developer and provider of consumer and professional medical diagnostic products. The company focuses on infectious disease, cardiometabolic disease, toxicology, clinical immunology, oncology and women's health. The company operates in North America, Asia Pacific, Europe, Middle East, Latin America and Africa. It is headquartered in Waltham, Massachusetts.